Amisulpride versus other atypical antipsychotics for schizophrenia
نویسندگان
چکیده
منابع مشابه
Clinical and Cost Consequences of Metabolic Effects of Lurasidone Versus Other Atypical Antipsychotics in Schizophrenia
Objective: To estimate the economic burden of hyperglycemia and diabetes associated with lurasidone versus other atypical antipsychotics in schizophrenia. Methods: A discrete event simulation model was developed to conduct the analysis from both US payer and societal perspectives over a 3-year timeframe. The model, based on the values of metabolic parameters at 1 year of treatment, identified p...
متن کاملNew atypical antipsychotics for schizophrenia: iloperidone
The optimal treatment of schizophrenia poses a challenge to develop more effective treatments and safer drugs, to overcome poor compliance, discontinuation and frequent switching with available antipsychotics. Iloperidone is a new dopamine type 2/serotonin type 2A (D(2)/5-HT(2A)) antagonist structurally related to risperidone, expected to give better efficacy with less extrapyramidal symptoms t...
متن کاملAtypical antipsychotics in the treatment of schizophrenia.
Over the last few years atypical antipsychotics have been used increasingly in the pharmacological treatment of schizophrenia. This review provides an overview of the pharmacological and clinical characteristics of atypical antipsychotics. In particular we discuss their efficacy in treating psychotic and negative symptoms as well as treatment-refractory patients. The most important side effects...
متن کاملdepot typical antipsychotics versus oral atypical antipsychotics in relapse rate among patients with schizophrenia: a five -year historical cohort study
objective: the present study aimed to review the relapse rate in patients with schizophrenia treated with orally taken atypical agents (serotonin dopamine antagonists, sdas) and depot preparation of conventional (typical) antipsychotics. methods: in this historical cohort study, mean relapse per month (mrm) index, duration between initiation of antipsychotic treatment and the first relapse epis...
متن کاملAtypical antipsychotics for people with both schizophrenia and depression.
BACKGROUND Many people (up to 50%) with schizophrenia also have co-morbid depression. It has been suggested that new atypical antipsychotic drugs are beneficial for people with the two diagnoses. OBJECTIVES To assess the effects of atypical antipsychotic drugs on people who have a diagnosis of both schizophrenia and depression. SEARCH STRATEGY We searched the Cochrane Schizophrenia's Group ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2010
ISSN: 1465-1858
DOI: 10.1002/14651858.cd006624.pub2